CheckMate 238 (NCT02388906) compared nivolumab with ipi10 and found that nivolumab produced superior RFS and had a more tolerable safety profile.[20] Pembrolizumab produced superior RFS compared with placebo, with data on OS still maturing in the MK-3475-054/KEYNOTE-054 trial (NCT02362594).[21] Dabrafenib plus trametinib produced superior RFS compared with placebo, with data on OS still maturing in the COMBI-AD trial (NCT01682083).[22] Single-agent BRAF-inhibitor therapy with vemurafenib did not show improved RFS compared with placebo in the BRIM8 trial (NCT01667419).[23] The benefit of immunotherapy with ipilimumab, nivolumab, and pembrolizumab has been seen regardless of programmed death-ligand 1 (PD-L1) expression or the presence of BRAF pathogenic variants
Temas Arte y arquitectura (118) Ciencias de la salud (65) Ciencias exactas y naturales (23) Ciencias silvoagropecuarias (27) Ciencias sociales (94) Comunicacin y medios (74) Derecho y ciencia poltica (173) Economa y administracin (22) Educacin (27) Filosofa y religin (44) Historia y geografa (231) Ingeniera y tecnologa (18) Literatura y lingstica (166) Unidades acadmicas Facultades Arquitectura y Urbanismo (67) Artes (43) Ciencias (15) Ciencias Agronmicas (38) Ciencias Fsicas y Matemticas (23) Ciencias Forestales y Conservacin (9) Ciencias Qumicas y Farmacuticas (2) Ciencias Sociales (102) Ciencias Veterinarias y Pecuarias (5) Derecho (64) Economa y Negocios (7) Filosofa y Humanidades (360) Medicina (113) Odontologa (11) Gobierno (17) Comunicacin e Imagen (97) Institutos Otros Archivo de la Arquitectura Chilena (24) Museo de Qumica y Farmacia (1) Escuela de Salud Pblica Dr
Labeling machine: Labeling Machine Labeling machine with high speed and efficient function considers as desirable to perform labeling of pharmaceutical products
- normal energy metabolism
When it comes to peptide therapy, how you handle your medication at home matters just as much as the treatment itself
117 XieY.HouW.SongX.YuY.HuangJ.SunX.et al (2016)
